Drug Standards
Medchemexpress LLC Hki-357 | 848133-17-5 | MFCD26792555 | 99.2% | 574.05 g·mol⁻¹ | C31H29ClFN5O3 | 25 MG
HKI-357 is a small-molecule, irreversible dual inhibitor of EGFR and ERBB2 used for research applications. It shows low-nanomolar potency (IC50 EGFR 34 nM; ERBB2 33 nM) and suppresses EGFR autophosphorylation at Y1068 and downstream AKT and MAPK signaling. Intended for research use only.
- Irreversible dual inhibition of EGFR and ERBB2 at low-nanomolar potency.
- Suppresses EGFR autophosphorylation (Y1068) and downstream AKT and MAPK signaling.
- Reported IC50s of 34 nM (EGFR) and 33 nM (ERBB2) for biochemical potency.
- High purity suitable for in vitro research and biochemical assays.
- Well-defined molecular formula and molecular weight facilitate analysis.
Med Vet International Zoetis Amoxi-Tabs, 200mg, 500ct.
VET LICENSE NEEDS TO BE PROVIDED IN 3-4 BUSINESS DAYS OR ORDER WILL BE CANCELLED
Amoxi-Tabs (amoxicillin) is a semisynthetic antibiotic with a broad spectrum of activity. It provides bactericidal activity against a wide range of common Gram-positive and Gram-negative pathogens. DOGS Indicated in the treatment of susceptible strains of the organisms causing the following infections in dogs: Respiratory tract infections (tonsillitis, tracheobronchitis), Genitourinary tract infections (cystitis). Gastrointestinal tract infections (bacterial gastroenteritis), Bacterial dermatitis due to Staphylococcus aureus, Streptococcus spp. , and Proteus mirabilis Soft tissue infections (abscesses, lacerations, and wounds) CATS Indicated in the treatment of susceptible strains of the organisms causing the following infections in cats: Upper respiratory tract infections, Genitourinary tract infections (cystitis), Gastrointestinal tract infections, Skin and soft tissue infections
Med Vet International Moxifloxacin Hcl .5% Ophthalmic Solution Yl 3mL
VET LICENSE NEEDS TO BE PROVIDED IN 3-4 BUSINESS DAYS OR ORDER WILL BE CANCELLED
Moxifloxacin HCL .5% Ophthalmic Solution Yl 3mL.
Medchemexpress LLC HKI-357 | 848133-17-5 | MFCD26792555 | 99.2% | 574.05 g/mol | C31H29ClFN5O3 | 100 MG
HKI-357 is a small-molecule, irreversible dual inhibitor of EGFR and ERBB2 with low-nanomolar potency. It inhibits EGFR (IC50 34 nM) and ERBB2 (IC50 33 nM), suppresses EGFR autophosphorylation at Y1068, and reduces AKT and MAPK phosphorylation. HKI-357 is used in biochemical assays and cell-based studies to probe EGFR/ERBB2 signaling and evaluate inhibitor activity in preclinical cancer research.
- Irreversible dual inhibitor of EGFR and ERBB2 with IC50s of 34 nM and 33 nM.
- Suppresses EGFR autophosphorylation (Y1068) and downstream AKT and MAPK phosphorylation.
- High purity (99.2% by HPLC) suitable for research applications.
- Available in milligram quantities for dose-ranging and assay setup.
- Suited for biochemical kinase assays and cell signaling studies.
Medchemexpress LLC Trimetrexate glucuronate | 82952-64-5 | 98.1% | 563.56 | C25H33N5O10 | 50 MG
Trimetrexate glucuronate is the mono-D-glucuronate conjugate of trimetrexate, an antifolate compound used in biochemical and pharmacological research. It is supplied as a research reagent and analytical standard for studies of antifolate activity and related metabolic profiling.
- High reported purity of 98.09% for reliable experimental use.
- Molecular weight 563.56 g/mol for stoichiometric calculations.
- Chemical formula C25H33N5O10 for structure-based applications.
- Supplied as a 50 mg sample suitable for laboratory assays.
- Commonly used as an analytical standard and research reagent in antifolate and antimicrobial studies.
Crescent Chemical Co Inc PARACETAMOL 250 MG
Paracetamol Pharma./veter. comp. (WS) CAS 103-90-2 Molecular Weight - 151.1626 Storage - RT Catalog Num - DRE-C15846000 pesticide
Cayman Chemical Glycopyrrolate 25mg
A mAChR antagonist (Kis = 0.42, 1.77, 0.52, 0.78, and 1.29 nM for the M1-M5 receptors, respectively); induces relaxation of precontracted isolated human bronchi at 0.01, 0.1, or 1 µM; reduces post-prandial gastric antral motility in dogs at 0.01 mg/kg; inhibits salivation in a rat model of pilocarpine-induced sialorrhea (ED50 = 0.74 UG/kg)
![eMolecules Medchem Express / KPT-6566 / 1mg / 489863088 / HY-123847 / / 881487-77-0 / [null] / 443.530 / C22H21NO5S2](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502460789.JPG-250.jpg)
eMolecules Medchem Express / KPT-6566 / 1mg / 489863088 / HY-123847 / / 881487-77-0 / [null] / 443.530 / C22H21NO5S2
Medchem Express / KPT-6566 / 1mg / 489863088 / HY-123847 / / 881487-77-0 / [null] / 443.530 / C22H21NO5S2
Sigma Aldrich Fine Chemicals Biosciences Trolamine impurity A Europ
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.for further information and support please go to the website of the issuing Pharmacopoeia.
Selleck Chemical LLC Cephalexin 50mg 15686-71-2 Cefalexin
Cephalexin (Cefalexin) is an antibiotic that can treat a number of bacterial infections. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
Selleck Chemical LLC Iloperidone 10mg 133454-47-4 HP873
Iloperidone (HP873) is a dopamine (D2)/serotonin (5-HT2) receptor antagonist, used for the treatment of schizophrenia. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
![Medchemexpress LLC N-(4-((3-chloro-4-fluorophenyl)amino)pyrido[3,4-d]pyrimidin-6-yl)-N'-(1-(dimethylamino)propan-2-yl)a | 848133-17-5 | MFCD26792555 | 99.2% | 574.05 | C31H29ClFN5O3 | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000245116.png-250.jpg)
Medchemexpress LLC N-(4-((3-chloro-4-fluorophenyl)amino)pyrido[3,4-d]pyrimidin-6-yl)-N'-(1-(dimethylamino)propan-2-yl)a | 848133-17-5 | MFCD26792555 | 99.2% | 574.05 | C31H29ClFN5O3 | 5 MG
HKI-357 is an irreversible small-molecule inhibitor of EGFR and ERBB2 kinases. It inhibits EGFR autophosphorylation at Y1068 and reduces downstream AKT and MAPK phosphorylation, showing potent activity in cell signaling and preclinical cancer models. Supplied as a solid research reagent for in vitro and preclinical studies.
- Irreversible dual inhibitor of EGFR and ERBB2
- Potent activity: EGFR 34 nM, ERBB2 33 nM
- Suppresses EGFR Y1068 autophosphorylation and downstream signaling
- Supplied as a solid, >99% purity (batch-dependent)
- Suitable for kinase signaling and preclinical cancer research
Medchemexpress LLC N-desalkylflurazepam | 2886-65-9 | MFCD00083443 | 100.0% | 288.70 g/mol | C15H10ClFN2O | 5 MG
N-desalkylflurazepam is a benzodiazepine metabolite supplied as a high-purity analytical standard for research and analytical applications. It is suited for chromatographic and mass spectrometric assays, method development, and quality control.
- Analytical standard for benzodiazepine metabolite testing.
- High purity for reliable reference and quality-control measurements.
- Molecular formula C15H10ClFN2O and molecular weight 288.70 g/mol.
- Available in small milligram pack sizes tailored for analytical use.
- Provided with datasheet detailing handling and storage.
Sigma Aldrich Fine Chemicals Biosciences Metformin impurity F European Pharmacopoeia (EP) Reference Standard | 506-59-2 | MFCD00012477 |
Metformin impurity F European Pharmacopoeia (EP) Reference Standard | Mol Wt: 81.54 | 506-59-2 | MFCD00012477 |